Sandbox:Sara: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}}; {{AE}} {{S.M.}}
{{CMG}}; {{AE}} {{S.M.}}


*Immunhistochemical staining of dermatofibrosarcoma protuberans shows:
*[[Immunhistochemistry|Immunhistochemical]] [[staining]] of dermatofibrosarcoma protuberans shows:
**Positive staining for:
**Positive [[staining]] for:
***CD34 (strong in 95%)
***[[CD34]] (strong in 95%)
***Vimentin
***[[Vimentin]]
***Focal actin
***Focal [[actin]]
***ApoD<ref name="pmid15252314">{{cite journal| author=West RB, Harvell J, Linn SC, Liu CL, Prapong W, Hernandez-Boussard T et al.| title=Apo D in soft tissue tumors: a novel marker for dermatofibrosarcoma protuberans. | journal=Am J Surg Pathol | year= 2004 | volume= 28 | issue= 8 | pages= 1063-9 | pmid=15252314 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15252314  }} </ref><ref name="pmid17885669">{{cite journal| author=Lisovsky M, Hoang MP, Dresser KA, Kapur P, Bhawan J, Mahalingam M| title=Apolipoprotein D in CD34-positive and CD34-negative cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma protuberans. | journal=Mod Pathol | year= 2008 | volume= 21 | issue= 1 | pages= 31-8 | pmid=17885669 | doi=10.1038/modpathol.3800971 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17885669  }} </ref><ref name="pmid20062007">{{cite journal| author=Bandarchi B, Ma L, Marginean C, Hafezi S, Zubovits J, Rasty G| title=D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans. | journal=Mod Pathol | year= 2010 | volume= 23 | issue= 3 | pages= 434-8 | pmid=20062007 | doi=10.1038/modpathol.2009.176 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20062007  }} </ref>
***ApoD
***bcl2
***[[Bcl2]]
***NKI-C3<ref name="pmid1553911">{{cite journal| author=Ma CK, Zarbo RJ, Gown AM| title=Immunohistochemical characterization of atypical fibroxanthoma and dermatofibrosarcoma protuberans. | journal=Am J Clin Pathol | year= 1992 | volume= 97 | issue= 4 | pages= 478-83 | pmid=1553911 | doi=10.1093/ajcp/97.4.478 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1553911  }} </ref>
***NKI-[[C3 (complement)|C3]]
***CD99<ref name="pmid18201229">{{cite journal| author=Diwan AH, Skelton HG, Horenstein MG, Kelly DR, Barrett TL, Bussian AH et al.| title=Dermatofibrosarcoma protuberans and giant cell fibroblastoma exhibit CD99 positivity. | journal=J Cutan Pathol | year= 2008 | volume= 35 | issue= 7 | pages= 647-50 | pmid=18201229 | doi=10.1111/j.1600-0560.2007.00872.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18201229  }} </ref>
***[[CD99]]
***Nestin
***[[Nestin (protein)|Nestin]]
***Tenascin
***[[Tenascin]]
***CD163
***[[CD163]]
***Factor XIIIa
***Factor XIIIa
***CD10
***[[CD10]]
**Negative staining for:
**Negative [[staining]] for:
***Factor XIIIa (usually)
***Factor XIIIa (usually)
***Keratin
***[[Keratin]]
***EMA
***EMA
***S100
***[[S100A1|S100]]
***HMB45
***HMB45
***Desmin
***[[Desmin]]
***CD117<ref name="pmid17944726">{{cite journal| author=Labonte S, Hanna W, Bandarchi-Chamkhaleh B| title=A study of CD117 expression in dermatofibrosarcoma protuberans and cellular dermatofibroma. | journal=J Cutan Pathol | year= 2007 | volume= 34 | issue= 11 | pages= 857-60 | pmid=17944726 | doi=10.1111/j.1600-0560.2007.00731.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17944726  }} </ref>
***[[CD117]]
<references />

Revision as of 23:25, 15 August 2019


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]